Dipna Pharmachem (BOM:543594) Interest Expense : ₹-22 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Dipna Pharmachem's interest expense for the six months ended in Sep. 2024 was ₹ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-22 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Dipna Pharmachem's Operating Income for the six months ended in Sep. 2024 was ₹ 15 Mil. Dipna Pharmachem's Interest Expense for the six months ended in Sep. 2024 was ₹ -10 Mil. Dipna Pharmachem's Interest Coverage for the quarter that ended in Sep. 2024 was 1.45. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dipna Pharmachem Interest Expense Historical Data

The historical data trend for Dipna Pharmachem's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Interest Expense Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

-3.27

-3.01

-6.08

-9.66

-20.12

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Interest Expense	Get a 7-Day Free Trial				-4.48	-5.18	-8.70	-11.42	-10.16

Dipna Pharmachem Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-22 Mil.

Dipna Pharmachem (BOM:543594) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dipna Pharmachem's Interest Expense for the six months ended in Sep. 2024 was ₹-10 Mil. Its Operating Income for the six months ended in Sep. 2024 was ₹15 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2024 was ₹149 Mil.

Dipna Pharmachem's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2024 )	/	Interest Expense (Q: Sep. 2024 )
	=	-1	*	14.715	/	-10.163
	=	1.45

The higher the ratio, the stronger the company's financial strength is.

Dipna Pharmachem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.

Dipna Pharmachem Headlines

No Headlines